CAS 65619-20-7
:Cyclohexanone, 4-(dimethylamino)-4-phenyl-
Description:
Cyclohexanone, 4-(dimethylamino)-4-phenyl-, also known by its CAS number 65619-20-7, is an organic compound characterized by its cyclohexanone structure, which features a ketone functional group. This compound contains a dimethylamino group and a phenyl group attached to the cyclohexanone ring, contributing to its unique chemical properties. It is typically a colorless to pale yellow liquid with a distinctive odor, and it is soluble in organic solvents. The presence of the dimethylamino group imparts basic properties, making it a potential candidate for various chemical reactions, including nucleophilic substitutions and electrophilic aromatic substitutions. Cyclohexanone derivatives are often utilized in the synthesis of dyes, pharmaceuticals, and agrochemicals. Safety considerations include handling it in well-ventilated areas and using appropriate personal protective equipment, as it may pose health risks upon exposure. Overall, this compound exemplifies the diverse applications and reactivity of substituted cyclohexanones in organic chemistry.
Formula:C14H19NO
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
4-(dimethylamino)-4-phenylcyclohexan-1-one
CAS:Formula:C14H19NOPurity:%Color and Shape:SolidMolecular weight:217.30684-(Dimethylamino)-4-phenylcyclohexan-1-one
CAS:<p>4-(Dimethylamino)-4-phenylcyclohexan-1-one</p>Purity:≥95%Color and Shape:SolidMolecular weight:217.31g/mol4-(Dimethylamino)-4-phenylcyclohexan-1-one
CAS:Controlled Product<p>Dimethylphencyclidine is a potent analgesic with high affinity for opioid receptors. It is an agonist at the μ-opioid receptor and κ-opioid receptor. Dimethylphencyclidine may also act as a nociceptive agent and has been shown to modulate pain in animals. This drug has also been shown to be neuropathic, as it inhibits the development of chronic constriction injury (CCI) in rats by reducing the formation of reactive oxygen species and increasing the expression of brain-derived neurotrophic factor (BDNF). Dimethylphencyclidine has undergone clinical trials for the treatment of neuropathic pain and is currently in phase II clinical development.<br>The pharmacological properties of dimethylphencyclidine are due to its ability to act on opioid receptors and other neurotransmitter systems, including serotonin, dopamine, acetylcholine, glutamate, and glycine. The chemical name for this drug is 4-(Dimethylamino)-4-phen</p>Formula:C14H19NOPurity:Min. 95%Molecular weight:217.31 g/mol
